Abstract Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166) is a glycoprotein
involved in homotypic and heterotypic cell adhesion. ALCAM can be proteolytically cleaved …

MicroRNAs are short regulatory RNAs that are able to post-transcriptionally modulate gene
expression and that have crucial roles in the control of physiological and pathological …

The plexiform lesions of severe pulmonary arterial hypertension (PAH) are similar in
histologic appearance, whether the disease is idiopathic or secondary. Both forms of the …

Activated leucocyte adhesion molecule (ALCAM) was originally identified as a
transmembrane receptor which is involved in T-cell activation and has other still unresolved …

Background: Activated leucocyte cell adhesion molecule (ALCAM, CD166) is a cell surface
member of the immunoglobulin superfamily. ALCAM expression has prognostic relevance in …

The activated leukocyte cell adhesion molecule [ALCAM/CD166/melanoma metastasis
clone D (MEMD)] is an immunoglobulin superfamily cell adhesion molecule. It is expressed …

Activated leukocyte cell adhesion molecule (ALCAM) or CD166 is a 100 to 105 KDa
transmembrane immunoglobulin which is involved in activation of T-cells, hematopoiesis …

Background Chimeric antigen receptor (CAR)-engineered T cells have displayed
outstanding performance in the treatment of patients with hematological malignancies …

Gene expression profiles were studied by microarray analysis in 2 sets of archival breast
cancer tissues from patients with distinct clinical outcome. Seventy‐seven differentially …

It has been suggested that the cAMP responsive element-binding protein (CREB) may act as
a transcription regulator of aromatase in breast cancer cells. However, there is little …